Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


House committee schedules DTC hearing

Executive Summary

The House Energy and Commerce Subcommittee on Oversight and Investigations has scheduled a May 8 hearing on direct-to-consumer advertising of drugs. The committee has not yet released a witness list, but the hearing agenda likely is to include discussion on Merck and Schering-Plough's failure to release ENHANCE trial data while running DTC ads for Vytorin (1"The Pink Sheet," Jan. 21, 2008, p. 10). The practice of using celebrities and doctors to endorse drugs in advertising, such as the appearance of artificial-heart inventor Robert Jarvik in ads for Lipitor, will likely also come up (2"The Pink Sheet," Jan. 14, 2008, In Brief)

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts